Please review the following URL and make sure that it is spelled correctly. Hydroxychloroquine is used to prevent or treat malaria infections caused by mosquito bites. Hydroxychloroquine type 2 diabetes fda Hydroxychloroquine long qt Plaquenil is a prescription medication approved by the Food and Drug Administration FDA to treat inflammation associated with lupus in people whose symptoms have not responded to drugs with lower risk for side effects. Plaquenil is also known by its drug name, Hydroxychloroquine. Hydroxychloroquine HCQ, sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria. Specifically it is used for chloroquine-sensitive malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth. Hydroxychloroquine Plaquenil is used to treat malaria, lupus, and rheumatoid arthritis. Learn about side effects, warnings, dosage, and more. The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. It does not work against certain types of malaria (chloroquine-resistant). Plaquenil for lupus Plaquenil Uses, Dosage & Side Effects -, Hydroxychloroquine - Wikipedia Tab hydroxychloroquine 200 mgHydroxychloroquine solution compoundPlaquenil retina toxicity Hydroxychloroquine is a one of a number of drugs which have been used for many years in the treatment of malaria. Fortunately, it was discovered these drugs often are helpful in the treatment of various rheumatic diseases, particularly systemic lupus erythematosus SLE or "Lupus" and rheumatoid arthritis. Plaquenil. A medication for Lupus. Hydroxychloroquine Side Effects, Dosage, Uses, and More. Protecting your eyesight when taking Plaquenil Lupus.. Some of the medications that may interact with Plaquenil include Arava lefunomide. Aurolate gold sodium thiomalate. Aubagio. Ferriprox. Mellaril. Sabril. Plaquenil is a DMARD which has been prescribed for years to treat rheumatoid arthritis, lupus, juvenile rheumatoid arthritis, and other autoimmune diseases. When the first biologic DMARD received FDA-approval in 1998, and as other biologics followed in subsequent years, it appeared as though Plaquenil would become less prescribed. Plaquenil hydroxychloroquine has been shown to improve physical function in up to 80% of patients with rheumatoid arthritis. Plaquenil hydroxychloroquine is commonly used for lupus in children because of less side effects compared to other medications. Plaquenil hydroxychloroquine helps minimize joint damage.